parfum de surface spray parfumé fleur de coton
ecolab deutschland gmbh -
rivomox 400 mg filmom obložene tablete
double-e pharma ltd., 7th floor, hume house, ballsbridge, dublin, irska - moksifloksacinklorid - filmom obložena tableta - 400 mg - urbroj: svaka filmom obložena tableta sadrži 400 mg moksifloksacina (u obliku klorida)
rivoxin 400 mg filmom obložene tablete
double-e pharma ltd., 17 corrig road, sandyford, irska - moksifloksacinklorid - filmom obložena tableta - 400 mg - urbroj: svaka filmom obložena tableta sadrži 400 mg moksifloksacina (u obliku moksifloksacinklorida)
utrogestan 100 mg/1 kapsula kapsula, meka
medis international d.o.o. sarajevo - progesteron - kapsula, meka - 100 mg/1 kapsula - 1 kapsula, meka sadrži: 100 mg progesterona
trusopt 2% kapi za oči, rastvor
"glosarij" druŠtvo sa ograniČenom odgovornoŠĆu za trgovinu, grafiČku djelatnost, proizvodnju i usluge-podgorica - dorzolamid - kapi za oči, rastvor - 2%
cosopt 2%+0.5% kapi za oči, rastvor
"glosarij" druŠtvo sa ograniČenom odgovornoŠĆu za trgovinu, grafiČku djelatnost, proizvodnju i usluge-cetinje - timolol, dorzolamid - kapi za oči, rastvor - 2%+0.5%
cosopt bez konzervansa 2% + 0.5% kapi za oči, rastvor
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - timolol, dorzolamid - kapi za oči, rastvor - 2% + 0.5%
lonsurf
les laboratoires servier - trifluridine, tipiracil hidroklorid - kolorektalne neoplazme - antineoplastična sredstva - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.